Randomized double-blind placebo-controlled pharmacodynamic evaluation of ONO-5129 in patients with treatment naive type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2012
At a glance
- Drugs ONO 5129 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Aug 2007 Status changed from in progress to completed.
- 03 Oct 2006 Status change
- 28 Nov 2005 New trial record.